Zapf, Antonia

[["dc.bibliographiccitation.firstpage","317"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Cells Tissues Organs"],["dc.bibliographiccitation.lastpage","326"],["dc.bibliographiccitation.volume","189"],["dc.contributor.author","Drengk, Anja"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Stuermer, Ewa Klara"],["dc.contributor.author","Stuermer, Klaus Michael"],["dc.contributor.author","Frosch, Karl-Heinz"],["dc.date.accessioned","2018-11-07T08:34:01Z"],["dc.date.available","2018-11-07T08:34:01Z"],["dc.date.issued","2009"],["dc.description.abstract","Background/Aims: Autologous chondrocyte (CC) transplantation has the disadvantages of requiring two surgical interventions and in vitro expansion of cells, implying the risk of cellular dedifferentiation. Our clinical aim is to develop a one-step procedure for autologous CC transplantation, i.e. harvesting, isolation and reimplantation of CC performed in one single surgical procedure. Platelet-rich plasma (PRP) is a source of autologous growth factors reported to have mitogenic effects. The objective of this study was to test the influence of PRP as an autologous scaffold on freshly isolated CC and mesenchymal stem cells (MSC). Methods: CC and MSC were subjected to two- or three-dimensional (3D) growth systems, either with or without PRP. Chondrogenic differentiation was determined via quantification of collagen type II mRNA and immunohistochemical staining. Results: We observed a proliferative effect for MSCs exposed to PRP in monolayer culture and an increase in the expression of chondrogenic markers when cells are exposed to a 3D environment. CCs exposed to PRP show a decrease in the chondrogenic phenotype with increasing proliferative activity. Conclusion: PRP has a proliferative effect on CCs and MSCs. In a one-step procedure for autologous CC transplantation, this might be an advantage over other scaffold materials, but confirmation in in vivo studies is required. Copyright (C) 2008 S. Karger AG, Basel"],["dc.identifier.doi","10.1159/000151290"],["dc.identifier.isi","000265178600002"],["dc.identifier.pmid","18689989"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/9312"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/17722"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Karger"],["dc.relation.issn","1422-6405"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Influence of Platelet-Rich Plasma on Chondrogenic Differentiation and Proliferation of Chondrocytes and Mesenchymal Stem Cells"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1149"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","European Radiology"],["dc.bibliographiccitation.lastpage","1156"],["dc.bibliographiccitation.volume","28"],["dc.contributor.author","Fasshauer, Martin"],["dc.contributor.author","Krüwel, Thomas"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Stahnke, Vera C."],["dc.contributor.author","Rave-Fränk, Margret"],["dc.contributor.author","Staab, Wieland"],["dc.contributor.author","Sohns, Jan M."],["dc.contributor.author","Steinmetz, Michael"],["dc.contributor.author","Unterberg-Buchwald, Christina"],["dc.contributor.author","Schuster, Andreas"],["dc.contributor.author","Ritter, Christian"],["dc.contributor.author","Lotz, Joachim"],["dc.date.accessioned","2020-12-10T14:10:11Z"],["dc.date.available","2020-12-10T14:10:11Z"],["dc.date.issued","2017"],["dc.identifier.doi","10.1007/s00330-017-5056-9"],["dc.identifier.eissn","1432-1084"],["dc.identifier.issn","0938-7994"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/70672"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Absence of DNA double-strand breaks in human peripheral blood mononuclear cells after 3 Tesla magnetic resonance imaging assessed by γH2AX flow cytometry"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","454"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","Melanoma Research"],["dc.bibliographiccitation.lastpage","461"],["dc.bibliographiccitation.volume","24"],["dc.contributor.author","Satzger, Imke"],["dc.contributor.author","Meier, Andre"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Niebuhr, Margarete"],["dc.contributor.author","Kapp, Alexander"],["dc.contributor.author","Gutzmer, Ralf"],["dc.date.accessioned","2018-11-07T09:34:54Z"],["dc.date.available","2018-11-07T09:34:54Z"],["dc.date.issued","2014"],["dc.description.abstract","In the case of a positive sentinel lymph node (SLN), melanoma patients are recommended to proceed to complete lymph node dissection (CLND). However, CLND for SLN-positive patients - especially with minimal tumor burden in SLN - is becoming more controversial. We analyzed the clinical course of 305 SLN-positive patients with a mean follow-up of 51.1 months by Kaplan-Meier analyses. Overall, 58/305 (17%) patients did not undergo CLND. These were compared with a matched selection of 58 comparable patients who underwent CLND. Moreover, 106/305 patients with minimal tumor burden in SLN (<0.1 mm diameter of the largest tumor deposit) were analyzed separately. Of these 106 patients, 34 did not undergo CLND, whereas 72/106 patients were treated by CLND. In the matched groups, the CLND group and the non-CLND group did not differ significantly with respect to clinical characteristics, characteristics of the primary melanoma, and histopathological parameters of SLN. There were no differences in recurrence-free survival (P = 0.765) and overall survival (P = 0.844). The total number of regional lymph node metastases and time to regional lymph node metastases were not significantly higher for non-CLND patients. The subgroup of patients with minimal tumor burden in SLN also did not benefit significantly from CLND. In our analyses from a single German center, we could not find any evidence for a therapeutic survival benefit for CLND after positive SLN. However, future prospective randomized trials should confirm these data. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins."],["dc.identifier.doi","10.1097/CMR.0000000000000081"],["dc.identifier.isi","000341979500006"],["dc.identifier.pmid","24811213"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/32278"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Lippincott Williams & Wilkins"],["dc.relation.issn","1473-5636"],["dc.relation.issn","0960-8931"],["dc.title","Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node?"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","362"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Journal of Stroke"],["dc.bibliographiccitation.lastpage","372"],["dc.bibliographiccitation.volume","20"],["dc.contributor.author","Schregel, Katharina"],["dc.contributor.author","Tsogkas, Ioannis"],["dc.contributor.author","Peter, Carolin"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Behme, Daniel"],["dc.contributor.author","Schnieder, Marlena"],["dc.contributor.author","Maier, Ilko L."],["dc.contributor.author","Liman, Jan"],["dc.contributor.author","Knauth, Michael"],["dc.contributor.author","Psychogios, Marios-Nikos"],["dc.date.accessioned","2021-06-01T10:48:59Z"],["dc.date.available","2021-06-01T10:48:59Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.5853/jos.2018.00605"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/86121"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-425"],["dc.relation.eissn","2287-6405"],["dc.relation.issn","2287-6391"],["dc.title","Outcome Prediction Using Perfusion Parameters and Collateral Scores of Multi-Phase and Single-Phase CT Angiography in Acute Stroke: Need for One, Two, Three, or Thirty Scans?"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","73"],["dc.bibliographiccitation.journal","Journal of Clinical Epidemiology"],["dc.bibliographiccitation.lastpage","82"],["dc.bibliographiccitation.volume","78"],["dc.contributor.author","Karch, Annika"],["dc.contributor.author","Koch, Armin"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Zerr, Inga"],["dc.contributor.author","Karch, Andre"],["dc.date.accessioned","2018-11-07T10:07:22Z"],["dc.date.available","2018-11-07T10:07:22Z"],["dc.date.issued","2016"],["dc.description.abstract","Objective: To investigate how choice of gold standard biases estimates of sensitivity and specificity in studies reassessing the diagnostic accuracy of biomarkers that are already part of a lifetime composite gold standard (CGS). Study Design and Setting: We performed a simulation study based on the real-life example of the biomarker \"protein 14-3-3\" used for diagnosing Creutzfeldt Jakob disease. Three different types of gold standard were compared: perfect gold standard \"autopsy\" (available in a small fraction only; prone to partial verification bias), lifetime CGS (including the biomarker under investigation; prone to incorporation bias), and \"best available\" gold standard (autopsy if available, otherwise CGS). Results: Sensitivity was unbiased when comparing 14-3-3 with autopsy but overestimated when using CGS or \"best available\" gold standard. Specificity of 14-3-3 was underestimated in scenarios comparing 14-3-3 with autopsy (up to 24%). In contrast, overestimation (up to 20%) was observed for specificity compared with CGS; this could be reduced to 0-10% when using the \"best available\" gold standard. Conclusion: Choice of gold standard affects considerably estimates of diagnostic accuracy. Using the \"best available\" gold standard (autopsy where available, otherwise CGS) leads to valid estimates of specificity, whereas sensitivity is estimated best when tested against autopsy alone. (C) 2016 Elsevier Inc. All rights reserved."],["dc.identifier.doi","10.1016/j.jclinepi.2016.03.022"],["dc.identifier.isi","000389615400010"],["dc.identifier.pmid","27107877"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/39262"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Elsevier Science Inc"],["dc.relation.issn","1878-5921"],["dc.relation.issn","0895-4356"],["dc.title","Partial verification bias and incorporation bias affected accuracy estimates of diagnostic studies for biomarkers that were part of an existing composite gold standard"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1980"],["dc.bibliographiccitation.issue","14"],["dc.bibliographiccitation.journal","Statistics in Medicine"],["dc.bibliographiccitation.lastpage","1998"],["dc.bibliographiccitation.volume","39"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Asendorf, Thomas"],["dc.contributor.author","Anten, Christoph"],["dc.contributor.author","Mütze, Tobias"],["dc.contributor.author","Friede, Tim"],["dc.date.accessioned","2021-04-14T08:26:15Z"],["dc.date.available","2021-04-14T08:26:15Z"],["dc.date.issued","2020"],["dc.description.abstract","In randomized clinical trials, it is standard to include baseline variables in the primary analysis as covariates, as it is recommended by international guidelines. For the study design to be consistent with the analysis, these variables should also be taken into account when calculating the sample size to appropriately power the trial. Because assumptions made in the sample size calculation are always subject to some degree of uncertainty, a blinded sample size reestimation (BSSR) is recommended to adjust the sample size when necessary. In this article, we introduce a BSSR approach for count data outcomes with baseline covariates. Count outcomes are common in clinical trials and examples include the number of exacerbations in asthma and chronic obstructive pulmonary disease, relapses, and scan lesions in multiple sclerosis and seizures in epilepsy. The introduced methods are based on Wald and likelihood ratio test statistics. The approaches are illustrated by a clinical trial in epilepsy. The BSSR procedures proposed are compared in a Monte Carlo simulation study and shown to yield power values close to the target while not inflating the type I error rate."],["dc.identifier.doi","10.1002/sim.8525"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/81880"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.eissn","1097-0258"],["dc.relation.issn","0277-6715"],["dc.rights","This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited."],["dc.title","Blinded sample size reestimation for negative binomial regression with baseline adjustment"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","12.e1"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","American Journal of Orthodontics and Dentofacial Orthopedics"],["dc.bibliographiccitation.volume","136"],["dc.contributor.author","Hahn, Wolfram"],["dc.contributor.author","Dathe, Henning"],["dc.contributor.author","Fialka-Fricke, Julia"],["dc.contributor.author","Fricke-Zech, Susanne"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Kubein-Meesenburg, Dietmar"],["dc.contributor.author","Sadat-Khonsari, Reza"],["dc.date.accessioned","2018-11-07T08:27:52Z"],["dc.date.available","2018-11-07T08:27:52Z"],["dc.date.issued","2009"],["dc.description.abstract","Introduction: The aim of the study was to quantify the forces delivered by thermoplastic appliances made of 2 materials with 2 thicknesses to a maxillary central incisor during tipping. Methods: Two materials were tested, each in 2 thicknesses: Erkodur (Erkodent Erich Kopp GmbH, Pfalzgrafenweiler, Germany) 1.0 and 0.8 mm, and Biolon (Dreve Dentamid GmbH, Unna, Germany), 1.0 and 0.75 mm. For each material, 5 appliances were produced. To measure the forces applied, an isolated measuring tooth, part of a standardized resin model, was deflected in 0.05 degrees steps from 0 degrees to 0.42 degrees in the vestibular and palatine directions, after placing the respective appliance on the model. For statistical analysis, the force components Fx/tipping and Fz/intrusion at a displacement of +/- 0.151 mm from the incisor edge were selected. Means and standard deviations were calculated. The Wilcoxon 2-sample test for group pairings was used. Results: The norms for the mean Fx forces ranged from 1.62 (SD, 0.41) to 5.35 N (SD, 0.63). The mean Fz forces were between 0.07 (SD, 0.13) and -2.47 N (SD, 0.34). The highest intrusive forces were measured during vestibular displacement of the measuring tooth. The forces delivered by the thick appliances were overall significantly higher (P < 0.0001) than those of the thin materials. The forces delivered by the Biolon appliances were generally significantly higher (P < 0.0001) than those for the Erkodur materials. Conclusions: The forces applied were mostly too high when compared with those stated in the literature as ideal. In addition to thickness, the thermoforming process influences the magnitude of the force delivered by a thermoformed appliance. (Am J Orthod Dentofacial Orthop 2009; 136: 12.e1-12.e7)"],["dc.identifier.doi","10.1016/j.ajodo.2008.12.015"],["dc.identifier.isi","000267695500009"],["dc.identifier.pmid","19577136"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/16295"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Mosby-elsevier"],["dc.relation.issn","0889-5406"],["dc.title","Influence of thermoplastic appliance thickness on the magnitude of force delivered to a maxillary central incisor during tipping"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","22"],["dc.bibliographiccitation.journal","Circulation"],["dc.bibliographiccitation.volume","128"],["dc.contributor.author","Sohns, Jan Martin"],["dc.contributor.author","Schulte, Christina"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Unterberg-Buchwald, Christina"],["dc.contributor.author","Staab, Wieland"],["dc.contributor.author","Kowallick, Johannes"],["dc.contributor.author","Preuss, Christoph"],["dc.contributor.author","Fasshauer, Martin"],["dc.contributor.author","Thuy-Trang Nguyen, Thuy-Trang Nguyen"],["dc.contributor.author","Paul, Thomas"],["dc.contributor.author","Lotz, Joachim"],["dc.contributor.author","Steinmetz, Michael"],["dc.date.accessioned","2018-11-07T09:17:27Z"],["dc.date.available","2018-11-07T09:17:27Z"],["dc.date.issued","2013"],["dc.identifier.isi","000332162907028"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/28173"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Lippincott Williams & Wilkins"],["dc.publisher.place","Philadelphia"],["dc.relation.conference","Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association"],["dc.relation.eventlocation","Dallas, TX"],["dc.relation.issn","1524-4539"],["dc.relation.issn","0009-7322"],["dc.title","Right Atrial Volume in Tetralogy of Fallot Correlates With the Incidence of Supra-Ventricular Arrhythmia: A MRI Study"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","e0135439"],["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","PLoS ONE"],["dc.bibliographiccitation.volume","10"],["dc.contributor.author","Brunkhorst, Lena Caroline"],["dc.contributor.author","Fichtner, Alexander"],["dc.contributor.author","Hoecker, Britta"],["dc.contributor.author","Burmeister, Greta"],["dc.contributor.author","Ahlenstiel-Grunow, Thurid"],["dc.contributor.author","Krupka, Kai"],["dc.contributor.author","Bald, Martin"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Toenshoff, Burkhard"],["dc.contributor.author","Pape, Lars"],["dc.date.accessioned","2018-11-07T09:51:29Z"],["dc.date.available","2018-11-07T09:51:29Z"],["dc.date.issued","2015"],["dc.description.abstract","Introduction Data on the efficacy and safety of everolimus in pediatric renal transplantation compared to other immunosuppressive regimens are scarce. Patients/Methods We therefore performed a multicenter, observational, matched cohort study over 4 years post-transplant in 35 patients on everolimus plus low-dose cyclosporine, who were matched (1: 2) with a control group of 70 children receiving a standard-dose calcineurin-inhibitor-and mycophenolate mofetil-based regimen. Results Corticosteroids were withdrawn in 83% in the everolimus vs. 39% in the control group (p<0.001). Patient and graft survival were comparable. The rate of biopsy-proven acute rejection episodes Banff score >= IA during the first year post-transplant was 6% in the everolimus vs. 13% in the control group (p = 0.23). The rate of de novo donor-specific HLA antibodies (11% in everolimus, 18% in controls) was comparable (p = 0.55). At 4 years post-transplant, mean eGFR in the everolimus group was 56 +/- 33 ml/min per 1.73 m(2) vs. 63 +/- 22 ml/min per 1.73 m(2) in the control group (p = 0.14). Everolimus therapy was associated with less BK polyomavirus replication (3% vs. 17% in controls; p = 0.04), but with a higher percentage of arterial hypertension and more hyperlipidemia (p<0.001). Conclusion In pediatric renal transplantation, an everolimus-based regimen with low-dose cyclosporine yields comparable four year results as a standard regimen, but with a different side effect profile."],["dc.description.sponsorship","Novartis Germany, Nuremberg, Germany"],["dc.identifier.doi","10.1371/journal.pone.0135439"],["dc.identifier.isi","000361800700005"],["dc.identifier.pmid","26407177"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/12219"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/35925"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Public Library Science"],["dc.relation.issn","1932-6203"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","161"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","Operative Dentistry"],["dc.bibliographiccitation.lastpage","171"],["dc.bibliographiccitation.volume","37"],["dc.contributor.author","Drebenstedt, Steffi"],["dc.contributor.author","Zapf, Antonia"],["dc.contributor.author","Roedig, Tina"],["dc.contributor.author","Mausberg, Rainer F."],["dc.contributor.author","Ziebolz, Dirk"],["dc.date.accessioned","2018-11-07T09:12:28Z"],["dc.date.available","2018-11-07T09:12:28Z"],["dc.date.issued","2012"],["dc.description.abstract","The aim of this study was to compare the effectiveness and duration of action of the tooth desensitization agent Cervitec (C) vs that of the new Cervitec Plus (C+). In this monocentric, single-center, three-armed, controlled, double-blind study, 120 subjects were randomly assigned to one of three groups: group I received Cervitec Plus (C+), group II received Cervitec (C), and group III received placebo (P). Varnishes were applied after baseline determination of cervical dentin hypersensitivity using a pain score of one or higher. Re-evaluation was performed 1, 7, 30, and 90 days after application. Statistical evaluation was carried out using nonparametric statistics for relative effects and analysis of variance (ANOVA). Thirty days after application of C and C+, all hypersensitivity decreased significantly in relation to baseline measurements (p < 0.001), with no changes taking place in the placebo group. Significant differences were observed between C and C+ vs placebo (p < 0.001), whereas no significant difference between C and C+ was seen after 30 days (p=0.840). After 90 days, the reduction in hypersensitivity with C+ was still significant compared with baseline measurements (p=0.001). However, C was not significantly different compared with baseline measurements (p=0.05). Analysis of all hypersensitive posterior teeth examined showed no significant difference between C and C+ after 90 days (p=0.362). For anterior teeth, the difference between C and C+ was significant (p=0.012). Both C and C+ reduce cervical tooth hypersensitivity, whereas C+ reduces hypersensitivity for a longer period of time."],["dc.description.sponsorship","Vivadent (Schaan, Liechtenstein)"],["dc.identifier.doi","10.2341/10-231-C"],["dc.identifier.isi","000311768100006"],["dc.identifier.pmid","22166108"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/26949"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Operative Dentistry Inc"],["dc.relation.issn","0361-7734"],["dc.title","Efficacy of Two Different CHX-Containing Desensitizers: A Controlled Double-Blind Study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]